Vir Biotechnology Presents Data on VIR-2218 from Clinical Studies for the Treatment of Hepatitis...
SAN FRANCISCO, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today announced that data from its VIR-2218 clinical program...
Scientists discover secreted protein helps both repair and grow muscles
Tokyo, Japan – Scientists from Tokyo Metropolitan University have discovered that a protein called platelet-derived growth factor subunit B (PDGF-B) is continuously secreted from skeletal muscle cells and helps to repair muscles by encouraging...
2/3 of parents cite barriers in recognizing youth depression
Teens and preteens are no strangers to depression: 1 in 4 parents say their child knows a peer with depression; 1 in 10 say a child’s peer has committed suicide
Credit: The C.S. Mott Children’s...
Insilico Medicine’s AI-designed drug ISM3412 receives FDA IND approval
Clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine ("Insilico") announces that it has received approval from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for ISM3412,...
Study gives insight into sun-induced DNA damage and cell repair
Breakthrough study fills a ‘missing gap,’ Baylor University researcher says
Credit: Robert Rogers/Baylor University
A team led by a Baylor University researcher has published a breakthrough article that...
Innovative approach for the development of next-generation cancer therapies targeting FGFR2/3
Aberrations in fibroblast growth factor receptors FGFR2/3 are major drivers of many cancers-including intrahepatic cholangiocarcinoma, endometrial, breast, gastric, and bladder cancers. However, the development of selective inhibitors targeted FGFR2/3 has long been challenged by...
Novotech webinar focuses on how to advance oncology clinical trials in the Asia-Pacific
Jul 15 2020
The leading Asia-Pacific biotech specialist CRO Novotech is again collaborating with the prestigious biotech and pharma news platform Endpoints News. This webinar focuses on how to advance oncology clinical trials in the...
Genome-First Strategy Identifies Deadly New Inflammatory Disorder in Men
Using a genotype-first strategy for disease discovery, a multidisciplinary team of NIH researchers has identified a new inflammatory disorder, called vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic syndrome (VEXAS), which is caused by mutations...
Many individuals with Niemann-Pick disease lack neutralizing antibodies against AAV2 or AAV9
A new study in the peer-reviewed journal Human Gene Therapy showed that more than half of individuals with Niemann-Pick disease, type C1 (NPC1) who were tested lacked neutralizing antibodies against either adeno-associated virus (AAV) 2 or...
Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated...
TUSTIN, Calif. and MORGAN HILL, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high...
